Bioventus Inc. Class A Common Stock BVS
$14.26
+2.66%
at last close
Market Cap$1.20 billion
P/E Ratio18.52
Div Yield—
Volume506.0K
52-Week Range
$5.81$15.89
Analyst Ratings
- Consensus
- Buy — 3 Buy · 0 Hold · 0 Sell (3 analysts)
- Avg. Price Target
- $15.00 (+5.2% upside)
Key Stats
- Today's Range
- $13.71 – $14.39
- 50-Day Range
- $8.39 – $15.89
- 52-Week Range
- $5.81 – $15.89
- Volume
- 506K shs
- Average Volume
- 818K shs
- Market Cap
- $1.20 billion
- P/E Ratio
- 18.52
- Dividend Yield
- —
Valuation
- P/E Ratio
- 18.52
- Price / Book
- 4.32
- Price / Sales
- 2.06
Short Interest
- Short Interest
- 0.78%
- Days to Cover
- 1.62
Financials (TTM)
- Revenue
- $581.85 million
- Net Income
- $61.48 million
- Net Margin
- 10.57%
- Return on Equity
- 22.16%
- Debt-to-Equity
- —
About Bioventus Inc. Class A Common Stock
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Related Stocks
Compare head-to-head: BVS vs SYK·BVS vs BSX·BVS vs RMD·BVS vs BAX
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.